Stockscreener 앱 받기
15.22
0.00%
0.00
시장 영업 전:
15.00
-0.22
-1.45%
전일 마감가:
$15.22
열려 있는:
$15.05
하루 거래량:
881.12K
Relative Volume:
1.38
시가총액:
$618.17M
수익:
-
순이익/손실:
$-168.05M
주가수익비율:
-2.9669
EPS:
-5.13
순현금흐름:
$-146.15M
1주 성능:
+1.26%
1개월 성능:
-4.52%
6개월 성능:
+3.89%
1년 성능:
-74.61%
1일 변동 폭
$14.86
$15.24
1주일 범위
$14.77
$15.47
52주 변동 폭
$9.12
$72.37
Keros Therapeutics Inc Stock (KROS) Company Profile
명칭
Keros Therapeutics Inc
전화
617-314-6297
주소
1050 WALTHAM STREET, SUITE 302, LEXINGTON, MA
KROS을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
KROS
Keros Therapeutics Inc
|
15.22 | 463.69M | 0 | -168.05M | -146.15M | -5.13 |
|
VRTX
Vertex Pharmaceuticals Inc
|
426.00 | 109.11B | 11.39B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
642.25 | 68.50B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
434.07 | 60.25B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ARGX
Argen X Se Adr
|
826.28 | 50.39B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
186.23 | 40.44B | 447.02M | -1.18B | -868.57M | -6.1812 |
Keros Therapeutics Inc Stock (KROS) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2025-10-20 | 개시 | Wells Fargo | Overweight |
| 2025-06-10 | 다운그레이드 | BofA Securities | Buy → Neutral |
| 2025-01-21 | 다운그레이드 | Cantor Fitzgerald | Overweight → Neutral |
| 2025-01-17 | 다운그레이드 | Wedbush | Outperform → Neutral |
| 2024-12-16 | 다운그레이드 | Guggenheim | Buy → Neutral |
| 2024-12-16 | 재확인 | Oppenheimer | Outperform |
| 2024-12-13 | 재확인 | H.C. Wainwright | Buy |
| 2024-12-12 | 다운그레이드 | BTIG Research | Buy → Neutral |
| 2024-12-12 | 다운그레이드 | TD Cowen | Buy → Hold |
| 2024-12-12 | 다운그레이드 | William Blair | Outperform → Mkt Perform |
| 2024-11-05 | 개시 | Jefferies | Buy |
| 2024-10-24 | 개시 | Cantor Fitzgerald | Overweight |
| 2024-10-16 | 개시 | Scotiabank | Sector Outperform |
| 2024-09-23 | 개시 | Guggenheim | Buy |
| 2024-06-25 | 개시 | Oppenheimer | Outperform |
| 2024-02-21 | 개시 | William Blair | Outperform |
| 2023-12-08 | 개시 | Wells Fargo | Overweight |
| 2023-07-31 | 개시 | Wedbush | Outperform |
| 2023-07-26 | 개시 | BofA Securities | Buy |
| 2023-02-14 | 개시 | Cowen | Outperform |
| 2022-10-18 | 개시 | Truist | Buy |
| 2022-07-26 | 개시 | BTIG Research | Buy |
| 2020-12-08 | 재확인 | H.C. Wainwright | Buy |
| 2020-05-04 | 개시 | H.C. Wainwright | Buy |
| 2020-05-04 | 개시 | Jefferies | Buy |
| 2020-05-04 | 개시 | Piper Sandler | Overweight |
| 2020-05-04 | 개시 | SVB Leerink | Outperform |
모두보기
Keros Therapeutics Inc 주식(KROS)의 최신 뉴스
Will Keros Therapeutics Inc. price bounce be sustainableAnalyst Downgrade & Expert Curated Trade Ideas - newser.com
Is Keros Therapeutics Inc. stock reversal real or fake2025 Top Decliners & Community Verified Trade Alerts - newser.com
Will Keros Therapeutics Inc. stock return to pre crisis levelsWeekly Investment Summary & High Conviction Buy Zone Alerts - newser.com
Evaluating Keros Therapeutics Inc. with trendline analysisTrade Risk Report & Target Return Focused Stock Picks - newser.com
Published on: 2025-11-03 06:15:55 - newser.com
Why Keros Therapeutics Inc. stock remains undervalued2025 Price Action Summary & Weekly Market Pulse Alerts - newser.com
Can volume confirm reversal in Keros Therapeutics Inc.2025 Historical Comparison & Reliable Price Breakout Signals - newser.com
Will a bounce in Keros Therapeutics Inc. offer an exitJuly 2025 PostEarnings & Detailed Earnings Play Strategies - newser.com
Y Intercept Hong Kong Ltd Invests $1.40 Million in Keros Therapeutics, Inc. $KROS - MarketBeat
How to recover losses in Keros Therapeutics Inc. stock2025 Winners & Losers & High Accuracy Trade Alerts - newser.com
Reversal indicators forming on Keros Therapeutics Inc. stockJuly 2025 Sentiment & Expert Verified Movement Alerts - newser.com
What hedge fund activity signals for Keros Therapeutics Inc. stockMarket Volume Report & Verified Trade Idea Suggestions - newser.com
Can trapped investors hope for a rebound in Keros Therapeutics Inc.Bull Run & Daily Risk Controlled Trade Plans - newser.com
How to manage a losing position in Keros Therapeutics Inc.Product Launch & Safe Entry Zone Tips - newser.com
Will Keros Therapeutics Inc. stock rally after Fed decisionsJuly 2025 Intraday Action & Safe Entry Point Alerts - newser.com
Published on: 2025-11-02 04:38:21 - newser.com
How interest rate cuts could boost Keros Therapeutics Inc. stockRate Hike & Breakout Confirmation Alerts - newser.com
Will Keros Therapeutics Inc. stock deliver consistent dividendsPortfolio Profit Report & Low Risk Profit Maximizing Plans - newser.com
Published on: 2025-11-01 09:22:31 - newser.com
Is Keros Therapeutics Inc. stock resilient to inflationQuarterly Growth Report & AI Forecast Swing Trade Picks - newser.com
Keros Therapeutics Inc expected to post a loss of $1.05 a shareEarnings Preview - TradingView
Keros Therapeutics, Inc. Experiences Revision in Its Stock Evaluation Amid Market Challenges - Markets Mojo
Keros Therapeutics (KROS) to Release Quarterly Earnings on Wednesday - MarketBeat
Is Keros Therapeutics Inc. stock attractive for income investorsJuly 2025 Closing Moves & High Accuracy Trade Alerts - newser.com
Keros Therapeutics Stock Fell 6.4% in a Month, What Now? - Trefis
How Keros Therapeutics Inc. stock reacts to bond yieldsPortfolio Profit Report & Daily Entry Point Trade Alerts - fcp.pa.gov.br
Published on: 2025-10-28 02:25:47 - newser.com
Keros Therapeutics Inc (KROS) 재무 분석
매출
순이익
현금흐름
주당 순 이익
0.64%
0.35%
자본화:
|
볼륨(24시간):